Results 181 to 190 of about 2,285,675 (298)

Risk of Non‐Arteritic Anterior Ischemic Optic Neuropathy in Idiopathic Intracranial Hypertension Patients Treated with GLP‐1 Receptor Agonists

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Introduction Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) have demonstrated significant weight‐reducing effects and may offer benefits in idiopathic intracranial hypertension (IIH); however, recent concerns about the risk of non‐arteritic anterior ischemic optic neuropathy (NAION) have emerged.
Faisal A. Al‐Harbi, Mohanad A. Alkuwaiti, Yazeed B. Alaql, Ahmed K. Alsaif, Ahmed A. Alessa, Meshari Ayed Alharbi, Mohammed Alfalah, Saud A. Alnaaim, Sajjad M. AlHaddad, Ahmed Y. Azzam   +9 more
wiley   +1 more source

Power Defect Detection with Improved YOLOv12 and ROI Pseudo Point Cloud Visual Analytics. [PDF]

Sensors (Basel)
Xu M, Peng J.
europepmc   +1 more source

Systematic Literature Review on Visual Analytics of Predictive Maintenance in the Manufacturing Industry. [PDF]

Sensors (Basel), 2022
Cheng X, Chaw JK, Goh KM, Ting TT, Sahrani S, Ahmad MN, Abdul Kadir R, Ang MC.   +7 more
europepmc   +1 more source

Sertraline Treatment Can Mimic Niemann‐Pick Type C Biomarker Profile: A Diagnostic Pitfall

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Oxysterols (cholestane‐3β,5α,6β‐triol and 7‐ketocholesterol) and N‐palmitoyl‐O‐phosphocholineserine (PPCS) are sensitive biomarkers for Niemann‐Pick disease type C (NPC) screening. However, false‐positive results occur, with a biomarker profile suggestive of NPC despite the absence of pathogenic variants in genes involved in NPC or ...
Maria Makrygianni, Cecile Pagan, Antony Citterio‐Quentin, Isabelle Rouvet, Giulia Dingeo, Cyril Hanin, Claudine Laurent‐Levinson, Samia Pichard, Bénédicte Héron, Clément Gourguechon, Daniele Mandia, Jerome Guitton, Carole Lacout, Nicolas Schleinitz, Florient Potier, Olivier Flabeau, Elsa Besse‐Pinot, Foudil Lamari, Magali Pettazzoni, Yann Nadjar   +19 more
wiley   +1 more source

The dark side of visual analytics

, 2017
Big data, complex computations, and the need for fluent interaction, are the well known enemies of Visual Analytics. They can seriously impair the fluent interactive back and forth between computational analysis and human analyst that happens using the ...
Marco Angelini, Giuseppe Santucci
core  

Retraction: Enhancing IoT cybersecurity through lean-based hybrid feature selection and ensemble learning: A visual analytics approach to intrusion detection. [PDF]

PLoS One
PLOS One Editors.
europepmc   +1 more source

The personalized cancer network explorer (PeCaX) as a visual analytics tool to support molecular tumor boards. [PDF]

BMC Bioinformatics, 2023
Figaschewski M, Sürün B, Tiede T, Kohlbacher O.   +3 more
europepmc   +1 more source

Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4‐IgG‐Positive NMOSD

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Rituximab (anti‐CD20, RTX) and inebilizumab (anti‐CD19, INE) represent B‐cell‐depleting therapies used for aquaporin‐4 antibody‐positive (AQP4‐IgG+) neuromyelitis optica spectrum disorder (NMOSD); however, direct comparative evidence remains limited.
Jie Lin, Binbin Xue, Dewei Xie, Jia Li, Juyuan Pan, Lanbing Zhu, Qiaowen Tong, Jing Lin, Ruofan Zhu, Xu Zhang, Junhui Xia, Xiang Li   +11 more
wiley   +1 more source

Knowledge mapping and research trends of chimeric antigen receptor T-cell immunotherapy in breast cancer: A bibliometric and visual analytics study. [PDF]

Hum Vaccin Immunother
Xu Y, Xu Y, Wang Z, Yi Q, Wang F, Bian P.   +5 more
europepmc   +1 more source

TriPlan: an interactive visual analytics approach for better tourism route planning. [PDF]

J Vis (Tokyo), 2023
Zhang X, Pang X, Wen X, Wang F, Li C, Zhu M.   +5 more
europepmc   +1 more source